Integer (NYSE:ITGR) announced its earnings results on Thursday. The medical equipment provider reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.17, Bloomberg Earnings reports. The firm had revenue of $390.50 million for the quarter, compared to analysts’ expectations of $358.42 million. Integer had a return on equity of 11.22% and a net margin of 1.42%. Integer’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.87 EPS. Integer updated its FY18 guidance to $3.15-3.45 EPS.
Shares of Integer (NYSE ITGR) traded up $0.05 during trading hours on Thursday, reaching $45.35. The company’s stock had a trading volume of 121,916 shares, compared to its average volume of 147,813. The firm has a market cap of $1,430.00, a PE ratio of 70.86, a PEG ratio of 0.96 and a beta of 1.04. The company has a current ratio of 2.58, a quick ratio of 1.37 and a debt-to-equity ratio of 1.95. Integer has a 52-week low of $33.90 and a 52-week high of $55.20.
ITGR has been the topic of a number of analyst reports. BidaskClub cut Integer from a “buy” rating to a “hold” rating in a report on Saturday, November 4th. TheStreet cut Integer from a “b-” rating to a “c+” rating in a report on Thursday, November 9th. ValuEngine upgraded Integer from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Zacks Investment Research upgraded Integer from a “sell” rating to a “buy” rating and set a $51.00 target price on the stock in a report on Wednesday, December 27th. Finally, Royal Bank of Canada reiterated a “neutral” rating on shares of Integer in a report on Friday, October 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $51.00.
In other news, VP Timothy G. Mcevoy sold 3,500 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $49.35, for a total transaction of $172,725.00. Following the sale, the vice president now owns 32,401 shares in the company, valued at $1,598,989.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William B. Summers, Jr. sold 13,996 shares of the firm’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $49.07, for a total value of $686,783.72. Following the sale, the director now owns 46,179 shares in the company, valued at approximately $2,266,003.53. The disclosure for this sale can be found here. In the last quarter, insiders have sold 64,286 shares of company stock worth $2,996,350. 4.80% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: “Integer (ITGR) Announces Earnings Results” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/22/integer-itgr-announces-earnings-results.html.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.